Dr. Nate Pennell from Cleveland Clinic reviews the LUME Lung-1
trial presented by Reck at ASCO 2013, of Taxotere with or without
nindetanib (BIBF-1120), an anti-angiogenic multikinase inhibitor,
in advanced NSCLC.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.